European Commission to Simplify the Procedures for Taking Part in EU-funded Research Projects

The overall aim is to make participation transparent and attractive to the best researchers and innovative companies in Europe and beyond. Ensuring European research realises its full potential is crucial to the EU's Europe 2020 Strategy, given the need to consolidate economic recovery and develop new sources of growth and jobs to replace those lost in the crisis. Complementing the proposals on simplification, the Commission has also appointed a group of independent experts to review all aspects of the current Seventh Framework Programme.

Research, Innovation and Science Commissioner Máire Geoghegan-Quinn said: "Our proposals aim to minimise administrative burdens in Europe's research programmes. We need to get the best researchers and most innovative companies taking part and we need to enable them to concentrate on results, not red tape. That will boost Europe's economy and quality of life. In particular, we must encourage more SME's to join in. I believe this can be done without compromising financial control. We are asking the other EU institutions for support to achieve this."

Budget Commissioner Janusz Lewandowski added: "The review of the Financial regulation which the Commission will present next month will underpin these ideas for simplifying research funding with concrete legal proposals, helpful also in many other policy areas. We need simpler rules to encourage potential beneficiaries of EU funds - such as small and medium enterprises or NGOs - to apply for them. Simplification means the EU budget serving citizens and businesses better."

The first part of the Commission's strategy will make improvements possible under the current legal and regulatory framework, some of which are already underway. These involve, for example, better IT systems, more consistent application of rules, in particular on auditing, and improving the structure and content of the "calls for proposals" in response to which research organisations bid for funding.

The second part involves changing the existing financial rules to allow more radical simplification while maintaining effective control, for example by widening the use of "average cost methodologies" that avoid the need for projects to account separately and painstakingly for each small item of expenditure. The Commission also aims to allow projects to use the same accounting methods for EU funding as they are required to use for national research funding. These proposals require a decision of the European Parliament and the Council.

The third type of change envisaged will be considered for implementation under future Research Framework Programmes. Among the options presented is a move towards "payment by results", which would mean that beneficiaries were paid lump sums to undertake specific scientific tasks and would need to demonstrate that they have done so effectively and efficiently, rather than to report individual cost items.

In the meantime, the Commission has launched the interim evaluation of the current Programme (FP7). A group of independent experts, chaired by Mr. Rolf Annerberg, has been appointed to undertake this review and present their report this autumn.

Mr Annerberg is Director General of the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas). The mandate of the group covers a wide range of issues related to the design, implementation and impact of Framework Programme activities.

Background
FP7 has proved very attractive to the research community with more than 33,000 proposals received since 2007, almost 7000 projects funded. Nearly all European universities participate.

Several concrete steps have already been taken towards simplification of procedures both in setting up FP 7 and since it has been in progress.

For example, FP7 introduced a new Guarantee Fund and a single registration facility meaning organisations applying for funding for several projects over several years need only enter their details once. Eight out of ten participants in FP7 are now exempt from ex-ante financial capacity checks and three out of four participants are exempt from providing certificates on financial statements needed for periodic cost claims.

Two new Executive Agencies were set up by the Commission in 2007: the Research Executive Agency (REA) and the European Research Council Executive Agency (ERC-EA). The European Research Council is a flagship component of FP 7 and awards grants to projects headed by starting and established researchers, with no requirement for projects to involve cross-border consortia.

For further information, please visit:
http://ec.europa.eu/research/fp7/index_en.cfm?pg=documents

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...